Suppr超能文献

β -[F]氟阿佐霉素阿拉伯糖苷(β -[F]FAZA):小鼠A431肿瘤的合成、放射性氟化及正电子发射断层显像初步研究

β -[F]Fluoro Azomycin Arabinoside (β -[F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors.

作者信息

Kumar Piyush, Roselt Peter, Reischl Gerald, Cullinane Carlene, Beiki Davood, Ehrlichmann Walter, Binns David, Naimi Ebrahim, Yang Jennifer, Hicks Rodney, Machulla Hans-Juergen, Wiebe Leonard I

机构信息

Department of Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2. Canada.

Peter McCallum Cancer Institute, Melbourne. Australia.

出版信息

Curr Radiopharm. 2017;10(2):93-101. doi: 10.2174/1874471010666170313120540.

Abstract

BACKGROUND

1-α-D-(5-Deoxy-5-[18F]fluoroarabinofuranosyl)-2-nitroimidazole([18F] FAZA) is a PET radiotracer that demonstrates excellent potential in imaging regional hypoxia, and is clinically used in diagnosing a wide range of solid tumors in cancer patients. [18F]FAZA, however, is radiofluorinated in only moderate recovered radiochemical yield (rRCY, ~12%). It is postulated that the relative stability of the C1' β-anomeric bond at C5' will make 1-β-D-(5-fluoro-5-deoxyarabinofuranosyl)-2-nitroimidazole (β-FAZA), the β-conformer of FAZA, an attractive candidate for clinical hypoxia imaging.

OBJECTIVES

The principle goals were to synthesize β-FAZA and β-Ac2TsAZA, the radiofluorination precursor, to establish the radiofluorination chemistry leading to β-[18F]FAZA, and to investigate the biodistribution of β-[18F]FAZA in an animal tumor-bearing model using PET imaging.

METHODS

The appropriately-protected furanose sugar was coupled with 2-nitroimidazole to afford 1-β-D-(2,3-di-O-acetylarabinofuranosyl)-2-nitroimidazole (β-Ac2AZA). Fluorination of β-Ac2AZA with DAST, followed by alkaline hydrolysis, afforded β-FAZA (21%). The radiolabeling synthon, 1-β-D-(5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl)-2-nitroimidazole (β-Ac2TsAZA), on radiofluorination using the 18F/K222 complex under various reaction conditions, followed by base-catalyzed deacetylation, afforded β-[18F]FAZA. β-[18F]FAZA was radiochemically stable for at least 8 h when stored in aqueous ethanol (8%) at 22 °C. A preliminary PET imaging-based biodistribution study of β-[18F]FAZA was performed in A431 tumor-bearing nude mice.

RESULTS

β-FAZA and β-Ac2TsAZA were synthesized in satisfactory yield. Radiochemistry of [18F]FAZA was established. PET images showed strong uptake in hypoxic regions of the tumor.

CONCLUSION

The synthesis of β-FAZA and β-[18F]FAZA are reported. Radiofluorination of β-Ac2TsAZA and the deprotection of β-Ac2[18F]FAZA were facile, but led to a more complex mixture of radiofluorinated by-products than observed with the corresponding precursor of α-[18F]FAZA. PET images were indicative of hypoxia-selective accumulation of β-[18F]FAZA in tumor.

摘要

背景

1-α-D-(5-脱氧-5-[18F]氟阿糖呋喃糖基)-2-硝基咪唑([18F]FAZA)是一种正电子发射断层显像(PET)放射性示踪剂,在成像局部缺氧方面显示出优异潜力,临床上用于诊断癌症患者的多种实体瘤。然而,[18F]FAZA的放射性氟化反应的放射性化学产率(rRCY)仅为中等水平(约12%)。据推测,C5'位C1'β-异头键的相对稳定性将使FAZA的β-构象体1-β-D-(5-氟-5-脱氧阿糖呋喃糖基)-2-硝基咪唑(β-FAZA)成为临床缺氧成像的一个有吸引力的候选物。

目的

主要目标是合成β-FAZA及其放射性氟化前体β-Ac2TsAZA,建立生成β-[18F]FAZA的放射性氟化化学方法,并使用PET成像研究β-[18F]FAZA在荷瘤动物模型中的生物分布。

方法

将适当保护的呋喃糖与2-硝基咪唑偶联,得到1-β-D-(2,3-二-O-乙酰基阿糖呋喃糖基)-2-硝基咪唑(β-Ac2AZA)。β-Ac2AZA用DAST氟化,随后进行碱性水解,得到β-FAZA(产率21%)。放射性标记合成子1-β-D-(5-O-甲苯磺酰基-2,3-二-O-乙酰基阿糖呋喃糖基)-2-硝基咪唑(β-Ac2TsAZA)在各种反应条件下使用18F/K222络合物进行放射性氟化,随后进行碱催化脱乙酰化,得到β-[18F]FAZA。β-[18F]FAZA在22℃下储存在8%乙醇水溶液中时,放射性化学稳定性至少为8小时。在荷A431肿瘤的裸鼠中进行了基于PET成像的β-[18F]FAZA生物分布初步研究。

结果

β-FAZA和β-Ac2TsAZA的合成产率令人满意。建立了[18F]FAZA的放射化学方法。PET图像显示肿瘤缺氧区域有强烈摄取。

结论

报道了β-FAZA和β-[18F]FAZA的合成。β-Ac2TsAZA的放射性氟化和β-Ac2[18F]FAZA的脱保护操作简便,但与α-[18F]FAZA的相应前体相比,产生的放射性氟化副产物混合物更复杂。PET图像表明β-[18F]FAZA在肿瘤中具有缺氧选择性蓄积。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验